Guizhou Bailing's net profit for the first three quarters of 347 million yuan is expected to increase by 10% to 40% year-on-year

On the evening of October 24th, Guizhou Bailing (002424, stock bar) released its first three quarters 2017 results. From January to September, the Company achieved operating income of RMB1,748 million, up 14.49% YoY, and net profit attributable to shareholders of listed companies was RMB347 million, up 10.43% YoY. In the third quarter, the company achieved operating income of RMB519 million, up 3.13% YoY, and net profit attributable to shareholders of listed companies was RMB108 million, up 10.12% YoY.
same time, Guizhou Bailing also issued its full-year 2017 results forecast, which forecast net profit attributable to shareholders of listed companies of RMB530 million to RMB675 million in 2017, up 10% to 40% YoY. Guizhou Bailing said that the company's current production and operation is normal, sales force is stable, sales of major products continue to grow steadily, the performance is expected to maintain steady growth.
Guizhou Bailing introduced, the company after years of efforts, now has a more perfect product structure, the first-line varieties of silver Dan heart and brain softgels, belonging to cardiovascular drugs, in recent years sales scale to achieve stable growth. Each line of products has formed a better scale, brand effect.
guizhou Bailing's heavy-weight products - sugar Ningtong project has been the focus of market attention. Guizhou Bailing in the interview with investors, the company Guiyang Chinese medicine diabetes hospital has been operating for more than two years, the performance achieved steady growth. At present, the sugar Ningtong capsule has been approved in the province more than 20 medical institutions to adjust the use. At the same time, in October this year, Guizhou Bailing and Hunan Samptang Investment Management Co., Ltd. signed an equity transfer agreement, the company will take full control of Changsha Diabetes Hospital. Guizhou Bailing introduced, this move can make the realization of the wholly-owned subsidiary resources for the overall planning and deployment, through management integration to enhance the overall operational efficiency of the hospital. (Securities Daily)